Pediatrix Medical Group Inc
BMV:MD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
280
323
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MXN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Pediatrix Medical Group Inc
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,800 full-time employees. The Company’s neonatal care provides clinical care to babies born prematurely or with complications within specific units at hospitals, primarily neonatal intensive care units, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners and other pediatric clinicians. The company offers maternal-fetal care, which provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians, such as maternal-fetal nurse practitioners and certified nurse mid-wives. The company provides other pediatric subspecialty care services, which includes other pediatric subspecialists, such as, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists.
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,800 full-time employees. The Company’s neonatal care provides clinical care to babies born prematurely or with complications within specific units at hospitals, primarily neonatal intensive care units, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners and other pediatric clinicians. The company offers maternal-fetal care, which provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians, such as maternal-fetal nurse practitioners and certified nurse mid-wives. The company provides other pediatric subspecialty care services, which includes other pediatric subspecialists, such as, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists.
Strong Earnings: Pediatrix reported third quarter adjusted EBITDA of $87 million, exceeding management’s expectations.
Full-Year Outlook: The company projects full-year adjusted EBITDA in a wider range of $270 million to $290 million, reflecting some variability in practice-level bonuses.
Share Buybacks: Pediatrix repurchased 1.2 million shares in the third quarter, with a total of 1.7 million shares bought back to date.
Cash Flow & Balance Sheet: Operating cash flow rose to $138 million, up from $96 million last year, and net leverage is now under 1x.
Pricing & Collections: Strong same-unit growth and pricing, driven by robust cash collections, higher patient acuity, favorable payer mix, and increased admin fees.
Portfolio Restructuring: Revenue declined due to portfolio restructuring, but the move has improved focus and operating performance.
Capital Allocation: Management remains cautious but active on share repurchases and sees potential for further acquisitions and internal investments.
